News

Servier Standardizes Data Across 80+ Countries With Veeva OpenData

Barcelona – September 30, 2026 -- Servier is standardizing customer reference data across more than 80 countries using Veeva OpenData, part of a global push to build an AI-ready data foundation for its commercial and medical teams.

Servier scales AI infrastructure after prior success with Veeva Link Key People

The French pharmaceutical company, governed by a Foundation, is harmonizing customer reference data globally to create a unified semantic layer that connects with Veeva Link. Liam Hanrahan, director of world operations excellence at Servier, said the move goes beyond process improvement, calling it the construction of a global data foundation designed to redefine how the company operates and scale AI across its affiliates.

Dar Global Revenue Jumps 66% to $258M as GDV Hits $23bn

Riyadh – September 30, 2026 -- Dar Global, the London-listed luxury developer, posted a 66% revenue increase to US$258.0 million for the six months ended June 30, 2026, up from US$155.4 million in HY 2025.

Net profit more than doubles as margins widen across the portfolio

Gross profit climbed 85% to US$87.7 million, lifting margins to 34% from 31% a year earlier. EBITDA rose 73% to US$46.3 million, while net profit surged 149% to US$30.4 million from US$12.2 million, driven by revenue recognition on The Astera, Interiors by Aston Martin, and Neptune, Interiors by Mouawad.

TrackVia Launches AI Layer IRIS, MCP Support, Rebuilt Android App

Denver – September 30, 2026 -- TrackVia has expanded its Field Operations Intelligence platform with a new artificial intelligence layer called IRIS, enterprise AI connectivity, a rebuilt Android application and a modernized web interface, targeting organizations managing complex field operations across construction, manufacturing, healthcare, hospitality, education and government.

Skilled-trade labor shortage drives platform upgrade

An August 2026 Lightcast analysis found roughly three open skilled-trade jobs for every qualified worker available to fill them. TrackVia CEO Aylin Basom said the company is responding to that gap by investing across AI, mobility, user experience, integrations and enterprise readiness rather than adding a single AI feature.

Novo Nordisk: Wegovy Pill Switch Study Shows 8.8 lb Loss in 3 Months

Plainsboro, New Jersey – – September 30, 2026 -- Adults with overweight or obesity who switched from injectable GLP-1 therapies to the oral Wegovy pill lost an average of 4.0 kg (8.8 lb) over three months, according to new real-world data from Novo Nordisk's OCTANE study presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan on September 30, 2026.

Patients switching to the oral formulation saw rapid weight-loss gains after three months

The retrospective analysis of 194 patients on the Ro telehealth platform found that 40.7% achieved weight loss of 5% or more within three months of switching from injectable semaglutide or tirzepatide to once-daily oral semaglutide (p0.001). The proportion of participants classified with a BMI of 30 kg/m2 or higher fell by 21.6 percentage points, dropping from 87.1% at baseline to 65.5% at the three-month mark.

Ro, Novo Unveil First Real-World Data on Wegovy Pill Switch at EASD2026

New York – September 30, 2026 -- Direct-to-patient healthcare company Ro presented the first real-world evidence on Novo Nordisk's oral Wegovy pill at the EASD2026 meeting in Milan on September 30, based on outcomes from patients on its platform who switched from an injectable GLP-1.

Ro's platform generates first clinical data on Wegovy pill switch patients

The short oral session study, co-authored by Ro clinical advisors Dr. Beverly Tchang and Dr. Louis Aronne, tracked patients with overweight or obesity who transitioned from an injectable GLP-1 and remained persistent with the Wegovy pill for three months on Ro's platform.

Astrocyte Raises $9.5M Series B as Concussion Drug Trial Completes Enrollment

Groton, Conn. – September 30, 2026 -- Astrocyte Pharmaceuticals Inc. has closed a $9.5 million Series B financing round to advance Phase 2 development of AST-004, its cerebroprotective therapy for concussion, traumatic brain injury (TBI) and stroke. The round brings total capital raised by the clinical-stage biotech, including grants, to $40 million.

DeepWork Capital leads financing with four new investors joining the round

The Series B was led by DeepWork Capital, with continued backing from existing investors and new participation from MintPharma Capital, Waterstar Capital, Dynagrow Capital and Angel Star Ventures. Jackson Streeter, M.D., Venture Partner at DeepWork Capital, said the firm has been impressed by the consistency of Astrocyte's science and the progress of its clinical programs.

Kenon to Pay $450M for 25% Stake in US District Energy Firm Vicinity

Singapore – – September 30, 2026 -- Kenon Holdings Ltd. has agreed to acquire a 25% equity interest in Vicinity District Energy for approximately $450 million, as part of a broader transaction valuing the company at $2.92 billion.

Antin Infrastructure Partners exits majority stake in $2.92 billion deal

The current owner, an entity related to Antin Infrastructure Partners, is selling a majority interest in Vicinity to a buyer jointly owned by Kenon and funds managed by Harrison Street Asset Management (HSAM). Under the Equity Purchase Agreement, the buyer will acquire between approximately 60% and 100% of Vicinity Holding Company. A consortium of lenders has committed non-recourse debt financing of up to $1.4 billion to fund part of the purchase price and future growth capital expenditures.

MEXC Tops SOL and DOGE Order Book Liquidity in CoinGecko 2026 CEX Study

Mutsamudu, Comoros – September 30, 2026 -- MEXC recorded the highest order book liquidity at market price for both SOL and DOGE among eight exchanges surveyed in CoinGecko Research's 2026 Crypto Liquidity on CEXes Report, which tracked the top five non-stablecoin assets over 60 days from July 6 to September 3, 2026.

MEXC posts $934,000 in SOL liquidity at market price, the study's top figure

CoinGecko found SOL liquidity more evenly distributed across venues in 2026 than the prior year, even as overall depth declined. MEXC held the lead at the immediate market price, though Bitget and Coinbase overtook it beyond the ±$0.20 range, indicating a more fragmented competitive field for SOL execution.

Epson Deploys 84 Laser Projectors for Anadol's AI Art Museum DATALAND

Los Angeles – – September 30, 2026 -- Media artist Refik Anadol has installed 84 synchronized Epson EB-PQ2220B 4K laser projectors to power Gallery A of DATALAND, the world's first Museum of AI Arts, which opened in Los Angeles in June 2026.

Data Pavilion delivers nearly 700 million pixels across mirrored architecture

The installation, known as the Data Pavilion, combines 84 units of Epson's 20,000-lumen projectors to generate over 1.5 million lumens and nearly 700 million pixels, transforming walls, floors, ceilings and mirrored columns into a continuous canvas. Camera-assisted software calibrates, aligns and edge-blends all 84 projectors into a single unified image in real time.

AGILINK Robotic Hand Masters Silk Embroidery, Hits 15,000 Units Shipped

Suzhou – – September 30, 2026 -- Chinese robotics firm AGILINK has shipped more than 15,000 dexterous robotic hands since spinning out from AGIBOT in January 2026, a scale-up that coincides with a demonstration of its OmniHand 3 Ultra performing traditional Suzhou embroidery.

Master craftswoman trains robotic hand on silk-thread techniques

Fu Xianghong, a Suzhou embroidery master, taught the OmniHand 3 Ultra foundational stitching skills including separating silk threads, threading a needle, stretching fabric on an embroidery hoop and stitching. Silk thread bends, slips and changes shape with slight contact variation, requiring one finger to isolate strands while others maintain tension, and opposing fingertips to twist thread without losing grip.

Subscribe to News